These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 26358709)

  • 41. Sentinel Node and Recurrent Breast Cancer (SNARB): results of a nationwide registration study.
    Maaskant-Braat AJ; Roumen RM; Voogd AC; Pijpers R; Luiten EJ; Rutgers EJ; Nieuwenhuijzen GA
    Ann Surg Oncol; 2013 Feb; 20(2):620-6. PubMed ID: 22941173
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improving the Success Rate of Repeat Sentinel Node Biopsy in Recurrent Breast Cancer.
    Vugts G; Maaskant-Braat AJ; Voogd AC; van Riet YE; Roumen RM; Luiten EJ; Rutgers EJ; Wyndaele D; Rutten HJ; Nieuwenhuijzen GA
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S529-35. PubMed ID: 26259754
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sentinel lymph node biopsy following previous axillary surgery in recurrent breast cancer.
    Sávolt Á; Cserni G; Lázár G; Maráz R; Kelemen P; Kovács E; Győrffy B; Udvarhelyi N; Vörös A; Ormándi K; Mátrai Z
    Eur J Surg Oncol; 2019 Oct; 45(10):1835-1838. PubMed ID: 31126680
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Staging and management of axillary lymph nodes in patients with local recurrence in the breast or chest wall after a previous negative sentinel node procedure.
    Derkx F; Maaskant-Braat AJ; van der Sangen MJ; Nieuwenhuijzen GA; van de Poll-Franse LV; Roumen RM; Voogd AC
    Eur J Surg Oncol; 2010 Jul; 36(7):646-51. PubMed ID: 20537838
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Repeat sentinel node biopsy should be considered in patients with locally recurrent breast cancer.
    Vugts G; Maaskant-Braat AJ; Voogd AC; van Riet YE; Luiten EJ; Rutgers EJ; Rutten HJ; Roumen RM; Nieuwenhuijzen GA
    Breast Cancer Res Treat; 2015 Oct; 153(3):549-56. PubMed ID: 26358709
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Repeat sentinel node biopsy in patients with locally recurrent breast cancer: a systematic review and meta-analysis of the literature.
    Maaskant-Braat AJ; Voogd AC; Roumen RM; Nieuwenhuijzen GA
    Breast Cancer Res Treat; 2013 Feb; 138(1):13-20. PubMed ID: 23340861
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Meta-analysis of aberrant lymphatic drainage in recurrent breast cancer.
    Ahmed M; Baker R; Rubio IT
    Br J Surg; 2016 Nov; 103(12):1579-1588. PubMed ID: 27598038
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
    Tvedskov TF
    Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sentinel node in the era of neoadjuvant therapy and locally advanced breast cancer.
    Trocha SD; Giuliano AE
    Surg Oncol; 2003 Dec; 12(4):271-6. PubMed ID: 14998567
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is regional nodes radiotherapy an alternative to surgery?
    Offersen BV; Nielsen HM; Overgaard M; Overgaard J
    Breast; 2013 Aug; 22 Suppl 2():S118-28. PubMed ID: 24074772
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic value and management of regional lymph nodes in locoregional breast cancer recurrence: a systematic review of the literature.
    Ge I; Erbes T; Juhasz-Böss I
    Arch Gynecol Obstet; 2022 Oct; 306(4):943-957. PubMed ID: 35122159
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Prognostic and curative value of sentinel node in breast cancer. A 377 patients experience].
    Iannace C; Di Libero L; Lepore M; De Stefano N; Buono M; Sciascia V; Manetta F; Giordano M; Scetta G; Varriale R; Esposito D; Tartaglia E; Ferbo U; Miletto P; Caracciolo F
    Ann Ital Chir; 2010; 81(2):103-11; discussion 112-3. PubMed ID: 20726388
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is axillary clearance the standard of care for breast cancer patients with sentinel node involvement?
    Fentiman IS
    Future Oncol; 2006 Oct; 2(5):621-6. PubMed ID: 17026453
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Omission of sentinel node biopsy for breast cancer: Historical context and future perspectives on a modern controversy.
    Jatoi I; Kunkler IH
    Cancer; 2021 Dec; 127(23):4376-4383. PubMed ID: 34614216
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The staging value of sentinel lymph node biopsy for breast cancer: translating pathologic findings to clinical practice.
    Bao J; Donovan C; Chung A; Giuliano AE
    Chin Clin Oncol; 2016 Jun; 5(3):36. PubMed ID: 27164851
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Management of the clinically node-negative axilla in primary and locally recurrent breast cancer.
    McGinity AC; Lautner MA; Jatoi I
    Surg Oncol Clin N Am; 2014 Jul; 23(3):463-71. PubMed ID: 24882345
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Key issues in sentinel node biopsy for breast cancer].
    Sawai K; Nakajima H; Mizuta N; Sakaguchi K; Hachimine Y
    Gan To Kagaku Ryoho; 2004 Aug; 31(8):1271-4. PubMed ID: 15332557
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.